SCHEMBL24596709

SCHEMBL24596709

CSc1ccc2c(c1)N(CCCN1CCC(C(=O)O)CC1)c1ccccc1S2

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 7/20 0.72
HRH1 P35367 7/20 0.72
DRD3 P35462 7/20 0.61
CYP2D6 P10635 6/20 0.61
SLC6A2 P23975 6/20 0.61
SLC6A4 P31645 6/20 0.61
ADRA2C P18825 5/20 0.61
HTR2A P28223 5/20 0.61
ADRA2A P08913 5/20 0.61
DRD1 P21728 5/20 0.61
ADRA2B P18089 4/20 0.61
HTR2B P41595 4/20 0.61
HTR2C P28335 3/20 0.61
CHRM5 P08912 2/20 0.61
ADRA1D P25100 2/20 0.61
HTR6 P50406 2/20 0.61
SIGMAR1 Q99720 2/20 0.61
KDM1A O60341 3/20 0.60
HTR1A P08908 5/20 0.57
ADRA1A P35348 5/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9677919 0.92 DRD2 (0.61) DRD2HRH1DRD3CYP2D6SLC6A2
SCHEMBL23898817 0.91 DRD2 (0.74) DRD2HRH1DRD3CYP2D6SLC6A2
SCHEMBL9677473 0.90 HRH1 (0.58) DRD2HRH1DRD3CYP2D6SLC6A2
SCHEMBL6966810 0.87 DRD2 (0.75) DRD2HRH1DRD3CYP2D6SLC6A2
SCHEMBL9678658 0.86 DRD2 (0.55) DRD2HRH1DRD3CYP2D6SLC6A2
SCHEMBL9676477 0.86 DRD2 (0.65) DRD2HRH1DRD3CYP2D6SLC6A2
SCHEMBL9678544 0.86 DRD2 (0.55) DRD2HRH1DRD3CYP2D6SLC6A2
SCHEMBL9676172 0.86 DRD2 (0.55) DRD2HRH1DRD3CYP2D6SLC6A2
Hydrochloric Acid SCHEMBL6969678 0.86 DRD2 (0.74) DRD2HRH1DRD3CYP2D6SLC6A2
SCHEMBL25918374 0.86 DRD2 (0.67) DRD2HRH1DRD3CYP2D6SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022146970-A1 METHODS OF METABOLIZING METOPIMAZINE AND ITS SALTS NEUROGASTRX, INC. (US) 2022-07-07 WO disclosed